- Home
- ALX vs PLSE Comparison
ALX vs PLSE Comparison
Compare ALX & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALX | PLSE |
|---|---|---|
| Founded | 1928 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | ALX | PLSE |
|---|---|---|
| Price | $217.30 | $13.32 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 59.3K | ★ 187.1K |
| Earning Date | 02-09-2026 | 11-05-2025 |
| Dividend Yield | ★ 8.22% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.14 | N/A |
| Revenue | ★ $215,838,000.00 | $86,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,002.94 |
| P/E Ratio | $30.65 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $184.76 | $12.56 |
| 52 Week High | $260.84 | $25.00 |
Technical Indicators
Market Signals| Indicator | ALX | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 49.76 | 38.71 |
| Support Level | $213.00 | $14.33 |
| Resistance Level | $221.99 | $14.91 |
| Average True Range (ATR) | 4.39 | 0.74 |
| MACD | 0.47 | -0.05 |
| Stochastic Oscillator | 47.78 | 4.84 |
Price Performance
Historical ComparisonAbout ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.